Afuco™ Anti-Human GLP-1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-GLP-1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies that bind to Glucagon-like peptide 1 (GLP-I) are using for treating metabolic disorders, enhancing insulin expression, and promoting insulin secretion.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-303CL |
| Pricing | Inquiry |
| Host | Human |
| Target | GLP-1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≤6 months at 4°C; ≥6 months at -20°C. |